Not recruiting yet
Comparison Between HUGO RAS Robotic Platform and Da Vinci Robotic Platform
NCT06844513 · IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated 25 Feb 2025
- What is being tested
- Radical prostatectomy; Partial nephrectomy
- For
- Prostate Cancer (Adenocarcinoma); Renal Cancer
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 800 people. The full rules are on the registry page.
- Where
- Italy
- When
- Starts or started 31 March 2025, ends 1 March 2033. Registered 25 Feb 2025.
- Results
- None posted yet.
In the researchers' words
The study is designed as a single-center, prospective, interventional, non-pharmacological, randomized, open-label, controlled trial with parallel groups. It targets patients with prostate cancer or kidney cancer who are candidates for robot-assisted surgical treatment, specifically radical prostatectomy (RP) or partial nephrectomy (PN).
Sites
- IRCCS Azienda Ospedaliero-Universitaria di BolognaBologna, Bologna, Italy